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Abstract

BACKGROUND: Although overall and disease-free survival remain the goals of cancer care,
health-related quality of life (HRQOL) during and after treatment is increasingly acknowledged
as vital to the patient’s outcomes. The purpose of this project was to identify and implement a
valid, reliable HRQOL assessment tool into daily clinical practice in an outpatient
hematology/oncology clinic at a 25-bed critical access hospital in rural New Hampshire.
METHODS: This project used a methodological design. Descriptive and inferential statistics,
plus qualitative analysis were used to determine results. Three nurses and seven patients
participated in this quality improvement project.
INTERVENTIONS: The interventions for this project included identifying a valid, reliable
HRQOL assessment tool; educating direct care providers on the use of the HRQOL assessment
tool; and capturing HRQOL data in the patient’s electronic medical record (EMR).
RESULTS: The FACT-G was identified and implemented into daily clinical practice.
Limitations of the licensing agreement prevented the project team from incorporating the FACTG into the EMR. Three nurses were educated on the use of the FACT-G. Seven patients
completed the assessment during the pilot period. Focus group results revealed the FACT-G
helped patients identify their symptoms and communicate their needs to providers.
CONCLUSIONS: Implementing a valid, reliable HRQOL assessment tool into daily clinical
practice at an outpatient hematology/oncology infusion suite at a critical access hospital in rural
New Hampshire was feasible and endorsed by both patients and providers. More data is needed
to determine if HRQOL assessments improve outcomes for cancer patients receiving treatment in
the outpatient setting.
Keywords: health-related quality of life, hematology, oncology, outpatient, quality improvement
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Implementing a Health-Related Quality of Life Assessment Tool in an Outpatient
Hematology/Oncology Clinic: A Pilot Quality Improvement Project
Cancer is the second leading cause of death in the United States and a significant public
health problem worldwide (Siegel et al., 2021). Medical advancements and the development of
evidence-based medicine have increased rates of survival and the overall quality of care delivery
for hematology/oncology patients (Sibeoni et al., 2018). As a result, cancer is now viewed as a
chronic disease, and patients must learn to cope with ongoing or cumulative side effects of
treatment while engaging in activities of daily living (Fragola, 2020). Although overall and
disease-free survival remain the goals of treatment for many patients and providers, healthrelated quality of life (HRQOL) during and after treatment has become an increasingly important
consideration in oncology care (Sitlinger & Zafar, 2018). Research demonstrates patients often
make treatment decisions based on their perceived HRQOL (Fragola, 2020). Thus, oncology
providers must incorporate valid, reliable HRQOL measures into their daily practice to ensure
treatment plans focus on the person rather than the disease (Fragola, 2020).
Problem Description
HRQOL is increasingly acknowledged as critical to the patient’s overall outcomes
(Sitlinger & Zafar, 2018). These measures are essential for prioritizing problems, understanding
what matters to the patient, and assessing changes the patient is experiencing (Fragola, 2020).
Capturing the patient experience through valid, reliable HRQOL measures is especially valuable
(Bridge et al., 2019). Research suggests a positive correlation between patient experience and
health outcomes, adherence to treatment and medications, preventative care, and health care
utilization rates. As a result, HRQOL data are often used to drive quality improvement efforts in
cancer care delivery and services (Bridge et al., 2019).
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Observation data for a rural critical access hospital indicate the organization did not
previously perform an HRQOL assessment on patients who receive treatment in their outpatient
hematology/oncology clinic (M. Miller, personal communication, June 3, 2021). Implementing a
valid, reliable HRQOL measure into daily clinical practice aligned with previous organizational
efforts to improve care delivery for this patient population. Additionally, the assessment scores
provide a baseline measure to support future quality improvement endeavors (M. Miller,
personal communication, June 3, 2021; S. Patton, personal communication, August 19, 2021).
For example, the HRQOL assessment scores can now be used to validate the need for dedicated
care management and palliative care services for these patients, both of which are nursing
priorities within the organization (S. Patton, personal communication, August 19, 2021).
Available Knowledge
To assess the current research on this issue, a literature search was performed using
MEDLINE and CINAHL, electronic databases covering all areas of nursing and allied health
care literature. Key search terms included “quality of life,” “health-related quality of life,”
“patient experience,” “oncology,” “hematology,” “cancer care,” “ambulatory care,” “outpatient
treatment,” “systematic review,” “quality improvement” and any combination of these terms.
The search parameters were refined so that only full-text, peer-reviewed articles published from
2008 to the present were included. Twelve articles were chosen for full-text review based on the
following inclusion criteria: the article discussed quality of life or health-related quality of life
measures, focused on the patient experience, and applied the intervention to cancer patients
receiving treatment in the ambulatory setting. Articles were excluded if they discussed quality of
life assessment in pediatric, inpatient, or non-oncology patient populations. Following a full-text
review, five articles were eliminated because they did not meet inclusion criteria. The remaining
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seven articles included a literature review (Shrestha et al., 2019) plus six articles relevant to the
design of this project (Atallah et al., 2021; Bridge et al., 2019; Fragola, 2020; Hilarius et al.,
2008; Sibeoni et al., 2018; Sitlinger & Zafar, 2018). Finally, information on cancer statistics for
2021 was gathered from Cancer, the journal published by the American Cancer Society.
Following this analysis, it is clear significant research data exists regarding the value of
using HRQOL assessments in ambulatory hematology/oncology settings. Most of the articles
focused on the link between quality of life and patient outcomes. One of the articles evaluated
the use of HRQOL assessments in daily clinical oncology nursing practice (Hilarius et al., 2008),
while another examined the feasibility of implementing a validated HRQOL measure in cervical
cancer patients receiving outpatient care (Atallah et al., 2021). A third article analyzed the
relationship between HRQOL and disease-related morbidity and mortality (Sitlinger & Zafar,
2018). Two of the studies used qualitative methodologies to report the lived experience of
patients receiving outpatient cancer treatment and its impact on their quality of life (Bridge et al.,
2019; Sibeoni et al., 2018). The final article focused on patient-reported outcomes and quality of
life assessment in multiple myeloma patients (Fragola, 2020).
Despite differences in purpose, population, and methodology, Hilarius et al. (2008),
Fragola (2020), and Sitlinger and Zafar (2018) concluded the availability of standardized
HRQOL data enhanced patient-provider communication, improved provider awareness of
patients’ problems, resulted in higher levels of patient satisfaction, and improved adherence to
treatment regimens. Shrestha et al. (2019), Bridge et al. (2019), and Sibeoni et al. (2018)
recognized that patients with cancer face difficult treatment decisions and must be involved in
their care to endure the impact treatment has on their quality of life. These studies also
acknowledge there is a growing need to understand the patient experience through HRQOL
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measures to drive improvements in cancer services and care delivery. Finally, Atallah et al.
(2021) determined it is feasible and acceptable to both patients and providers to implement a
validated HRQOL measure in an ambulatory oncology clinic. Together, these findings
demonstrate that gathering and evaluating HRQOL data is an essential component of providing
cancer care and improving patient outcomes in the ambulatory setting.
Rationale
Plan-Do-Study-Act (PDSA) was the quality improvement (QI) methodology for this
project. Using the PDSA cycle promoted a small-scale, iterative approach to test interventions,
which enabled rapid assessment and provided flexibility to adapt interventions as needed to
ensure acceptable, fit-for-purpose solutions were developed and implemented (Taylor et al.,
2014).
Specific Aims
The primary aim of this project was to identify and implement a valid, reliable HRQOL
assessment tool in an outpatient hematology/oncology clinic at a small critical access hospital in
rural New Hampshire by the end of the pilot period. A secondary aim was to educate clinic
providers on the HRQOL assessment tool and integrate its use into the clinic’s daily workflow. A
final goal was to incorporate the HRQOL assessment tool into the organization’s electronic
medical record by the end of the pilot period.
Context
Setting
The facility where the project took place is a 25-bed critical access hospital in central
New Hampshire (NH). Critical access hospital (CAH) status is awarded by the Centers for
Medicare and Medicaid Services (CMS) to qualifying rural hospitals that meet specific eligibility
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criteria. Namely, the facility must have 25 or fewer acute care inpatient beds, be located more
than 35 miles from another hospital, maintain an average length of stay of 96 hours or less for
acute care patients, and provide emergency services 24 hours per day, 7 days per week (Centers
for Medicaid & Medicare Services [CMS], 2013). Organizations with CAH status receive costbased reimbursement from Medicare. Thus, CAH designation reduces the financial vulnerability
of rural hospitals and improves access to health care by keeping essential services in rural areas
(CMS, 2013). As a CAH, the hospital provides primary care and specialized clinical services to
15 communities in the Lake Sunapee region. Additionally, the organization has a collaborative
agreement with Dartmouth-Hitchcock Medical Center (DHMC) and is part of Dartmouth Health
(D-H), the state’s only academic health system (New London Hospital, 2021).
The primary site for this intervention was the hospital’s hematology/oncology infusion
suite, an outpatient clinic located within the main hospital complex in New London, NH. The
clinic has an open floor plan with four chairs, separated by partitions, where individuals receive
treatment, plus a small private room in the back for immunocompromised patients and their
families. The clinic is open Monday through Friday from 8 am to 4:30 pm and is always staffed
by two registered nurses (RNs) who are trained to administer chemotherapy and biotherapy
agents. Five to ten patients are treated each day, most days of the week (M. Miller, personal
communication, June 3, 2021). All told, approximately 250 patients access services through the
hematology/oncology infusion suite each year (Amber Bailey, personal communication,
September 17, 2021).
Staff Characteristics
Each patient is cared for by a multidisciplinary team, which consists of the attending
physician, an RN, and a pharmacist. Patients also have limited access to supportive services such
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as care management, social work, and palliative care when needed based on their unique
circumstances. Finally, in addition to the direct care providers mentioned above, a host of other
staff also interact with patients every visit including administrative personnel, dietary,
housekeeping, and volunteers (M. Miller, personal communication, June 3, 2021).
The leadership team includes the associate chief nursing officer, who provides clinical
support to the hematology/oncology infusion suite, and the clinical nurse supervisor, who
oversees day-to-day operations in the clinic and provides direct patient care. There is one
attending physician on staff. He sees patients in the clinic every Monday. Tuesday through
Friday he is available by telephone for any issues that arise. Additionally, the full patient care
team meets every Thursday to review current patients and discuss any changes to their treatment
plan (M. Miller, personal communication, June 3, 2021).
The clinic employs three full-time RNs. Additional nursing and supportive care services
are provided by medical assistants (MAs) as needed. Most of the nursing staff work four ninehour shifts per week. The skill mix of the staff is varied. Some are just off orientation, while
others have years of experience caring for hematology/oncology patients. The nursing staff are
responsible for all care coordination and delivery during the patient’s visit as well as telephone
triage services outside of the appointment (S. Patton, personal communication, September 16,
2021). In general, the culture is one of shared responsibility and teamwork. It is a warm,
welcoming environment, and the nursing staff try to help one another as much as possible.
Patient Characteristics
The hematology/oncology infusion suite provides comprehensive medical care to adults
with cancer, blood disorders, and specific non-cancer-related conditions such as multiple
sclerosis. When a new diagnosis is made, patients who live in the Lake Sunapee region are
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referred to the hematology/oncology infusion suite by their primary care provider, hematologist,
oncologist, or nurse case manager. The amount of time each patient spends in the infusion suite
per visit varies based on their diagnosis and treatment plan, as does the total number of visits
needed. Some patients spend just a few minutes in the clinic and only require one visit, while
others are there for several hours’ multiple times each week. Patients may or may not see the
attending physician during their visit. Most patients are followed by healthcare providers in the
wider D-H system and receive infusions or injections at the hematology/oncology infusion suite
because it is closer than traveling to the main D-H campus in Lebanon to receive care. All
patients seen in the hematology/oncology infusion suite are over the age of 18 (M. Miller,
personal communication, June 3, 2021).
Cost Benefit Analysis/Budget
An HRQOL assessment tool in the public domain was selected so there were no
copyright or usage fees associated with adopting the measure. Nursing staff working in the
hematology/oncology infusion suite received training on how to utilize the HRQOL assessment
tool during regular business hours so there were no training costs associated with the project,
either (S. Patton, personal communication, September 17, 2021). As such, there were no costs
associated with implementing the intervention. Finally, although the hospital did not receive
direct monetary gain by implementing the HRQOL assessment tool, adopting the measure has
improved communication regarding HRQOL issues between hematology/oncology patients and
the providers in the outpatient infusion suite. Additionally, the assessment scores provide a
baseline measure for future quality improvement projects within the organization.
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Interventions

The interventions for this project included:
•

Creating a project team consisting of the chief nursing officer, associate chief nursing
officer, director of quality and safety, and the clinical nurse supervisor of the outpatient
hematology/oncology infusion suite to examine the issue of HRQOL assessment in
hematology/oncology patients.

•

Searching the existing nursing and allied health care literature for valid, reliable HRQOL
assessment tools.

•

Identifying a valid, reliable HRQOL measure in the public domain that was easy to
administer, took less than 10 minutes to complete, and produced a quantitative score that
could be tracked over time.

•

Educating direct care providers in the hematology/oncology infusion suite on the use of
the HRQOL measure and the rationale behind collecting HRQOL data.

•

Capturing HRQOL data in the patient’s electronic medical record (EMR).

•

Collecting quantitative data related to the number of HRQOL assessments performed
within the first six-weeks post-intervention along with qualitative information regarding
ease of use and barriers to implementation.

•

Developing a policy, procedure, and job aids to sustain and standardize administration of
the assessment.

•

Measuring the success of the intervention through patient-level review, weekly data
reviews, and progress towards the project goals.

•

Using the assessment scores as a baseline measure to support future quality improvement
initiatives within the organization.
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Disseminating the intervention to other outpatient hematology/oncology infusion suites
within the D-H system, as appropriate.
Study of the Interventions
The design for this project was a methodological literature review. Strict inclusion and

exclusion criteria were applied to identify a valid, reliable HRQOL assessment tool. For this
project, the outcome of interest was health-related quality of life (HRQOL). The population of
interest was adult cancer patients receiving treatment in the outpatient hematology/oncology
infusion suite at a CAH in rural NH. The primary interventions were the identification of a valid,
reliable HRQOL assessment tool followed by an education session for direct care providers on
HRQOL measures, implementation of the HRQOL assessment tool into daily clinical practice,
and the development of a policy, procedure, and job aids to standardize use of the assessment.
Chart reviews were conducted at specific intervals by RNs in the hematology/oncology infusion
suite in the first six weeks post-implementation to determine if HRQOL assessments were being
conducted on eligible patients. Qualitative data from the nursing staff and a
hematology/oncology patient was also collected via a focus group to identify ease of use and
barriers to implementation. These results were used to further refine the implementation process
and establish organizational benchmarks regarding HRQOL assessments and specific nursing
interventions for follow-up care in the population of interest.
Measures
Health-related quality of life (HRQOL) is recognized as a multidimensional concept.
HRQOL includes domains related to physical, psychological, and social functioning. It
represents the patient’s perception of how disease and treatment affect their sense of overall
function and well-being (Office of Disease Prevention and Health Promotion [ODPHP], 2021).
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For this project, HRQOL was defined as an individual’s perceived physical and mental health
over time (Centers for Disease Control and Prevention [CDC], 2021).
The outcome measure for this project was assessment of health-related quality of life in
cancer patients. This outcome measure is designed to capture the percentage of eligible cancer
patients who complete a self-reported health-related quality of life assessment with or without
assistance using a valid, reliable HRQOL assessment tool at least once per calendar year. The
numerator for this measure is the number of eligible patients, treated at the organization’s
hematology/oncology infusion suite, who complete the assessment with or without assistance at
least once per year. The denominator for this measure is the total number of patients receiving
treatment at the organization’s hematology/oncology infusion suite annually, minus those
individuals who meet exclusion criteria. The measure is calculated by dividing the numerator by
the denominator, then multiplying the result by 100 (National Quality Forum [NQF], 2017). A
similar measure, assessment of health-related quality of life in dialysis patients, was endorsed by
the National Quality Forum (NQF) in 2017.
The target population for this measure was adult cancer patients receiving treatment in
the outpatient setting. Patients were excluded from the assessment if they did not have a cancer
diagnosis, were under the age of 18, were unable to complete the assessment due to mental status
that could invalidate the results, were non-English speaking/reading and no native language
translation or interpreter was available, or they declined to complete the assessment (NQF,
2017).
Analysis
Descriptive statistics were used to calculate the percentage of eligible patients with a
completed HRQOL assessment within the first six-weeks post-implementation. Inferential
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statistics, specifically the dependent t-test was used to assess improvement in the nursing staff’s
knowledge surrounding (a) the importance of capturing HRQOL data in adult
hematology/oncology patients undergoing outpatient treatment and (b) use of the HRQOL
assessment tool. Qualitative data was gathered via a focus group. The focus group data was
transcribed so relevant themes could be identified and summarized. Finally, overall improvement
was measured by calculating the number of eligible patients undergoing HRQOL assessment at
baseline and comparing it to the number of eligible patients undergoing HRQOL assessment
post-implementation.
Ethical Considerations
Ethical considerations for this project included the protection of personal health
information. Each patient authorized consent to treat on arrival to the hematology/oncology
infusion suite and was, therefore, protected by the Health Insurance Portability and
Accountability Act (HIPAA). All project-related data was collected according to the standards of
privacy and confidentiality outlined in the organization’s internal policies and procedures. Due to
the nature of this project, special considerations such as HIV/AIDs status, substance abuse,
sexually transmitted diseases, and genetic testing results were not applicable. Data was coded so
that participants could not be identified, and no patient-identifying information left the building.
Data was stored on a password protected device that could only be accessed by the project team.
Finally, to ensure the project met the standards of a quality improvement initiative, not research,
a project proposal was submitted to and approved by the University of New Hampshire’s Quality
Improvement Review Board as well as the quality improvement team at the participating
organization.

HRQOL ASSESSMENT

16
Results

The project was divided into three phases. Figure 1 summarizes the project timeline.
Phase I involved searching the existing nursing and allied health care literature and identifying a
valid, reliable HRQOL assessment tool. During Phase II, RN staff in the outpatient
hematology/oncology infusion suite were educated on the assessment tool, it was implemented
into the daily workflow of the clinic, and patients who met the inclusion criteria were assessed.
Phase III involved creating a policy, procedure, and job aids to standardize use of the HRQOL
assessment tool and sustain the project.
Figure 1
Project Timeline
11/4

4/8

11/19-3/11

• Project
approved

•Project
complete

•Phase II

11/7-11/18
•Phase I

3/12-4/8

•Phase III

Phase I – Identifying a HRQOL Assessment Tool
Three valid, reliable HRQOL assessment tools in the public domain were reviewed by the
project team. After careful consideration, the Functional Assessment of Cancer Therapy –
General (FACT-G) was identified as the best HRQOL assessment tool to implement into clinical
practice within the outpatient hematology/oncology infusion suite. The FACT-G (Appendix A)
was chosen due to its ease of use, and simple, straightforward questions. The assessment is selfadministered by the patient, takes approximately five minutes to complete, and consists of 27
questions that measure four key domains – physical well-being, social/family well-being,
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emotional well-being, and functional well-being – using a 5-point Likert-type numeric ranking
system (Functional Assessment of Chronic Illness Therapy [FACIT] Group, 2021).
The FACT-G is one of the most widely used patient-reported HRQOL outcomes
measures in cancer research. It measures HRQOL in cancer patients undergoing treatment and
can be used with patients who have any type of malignancy. Patients mark their response to the
questions in each domain based on the symptoms they have experienced in the past seven days.
Although patients can skip items, they are encouraged to complete every item in order without
skipping any to produce the most accurate scores (FACIT Group, 2021).
The assessment produces both a total score and four subscale scores that can be tracked
over time. Scoring is completed manually by the provider once the patient has finished the
assessment. Some of the items are reverse scored. To improve ease of use and accuracy, an Excel
spreadsheet was created with imbedded formulas to reverse score items and calculate each
subscale score as well as the overall assessment score. Patients who score highly on each
subscale as well as the overall assessment have a higher level of well-being and increased quality
of life (FACIT Group, 2021).
Originally, the project team was going to create a custom note template for the FACT-G
assessment and score sheet in the organization’s EMR prior to implementing it into daily clinical
practice. However, as part of the licensing agreement with the Functional Assessment of Chronic
Illness Therapy [FACIT] Group (2021), which developed the FACT-G assessment, the hospital
discovered it was not possible to incorporate the FACT-G assessment into its EMR. The
licensing agreement with the FACIT Group (2021) states the license is for the licensee’s use only
and may not be used by software vendors with access to the licensee’s EMR. Since the hospital’s
EMR is managed by a third-party vendor, Epic Systems, this clause in the licensing agreement
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required the project team to pivot and administer the assessment on paper. To ensure all
providers had access to the results, completed FACT-G assessments were scanned into the
patient’s medical record. Additionally, the date the FACT-G assessment was administered, along
with the patient’s subscale scores and their overall assessment score, was recorded in the
narrative note for each patient’s encounter in the EMR.
Phase II – Implementing the FACT-G
The project team determined the FACT-G should be administered to eligible patients at
least three times during the treatment process – once prior to the initiation of treatment to
establish a baseline; once during treatment; and once at the conclusion of treatment to track the
patient’s HRQOL over time.
Prior to implementing the FACT-G assessment, a 15-question HRQOL survey was
administered to the RN staff of the outpatient hematology/oncology infusion suite (n = 3). The
survey was designed to assess their knowledge of HRQOL measures in cancer patients and
determine if they consistently incorporated assessment of HRQOL measures into their daily
practice. Per the results, 66% of the respondents were comfortable asking hematology/oncology
patients about HRQOL measures (Table 1) and 100% of respondents stated they felt
knowledgeable about HRQOL measures in hematology/oncology patients (Table 2). Despite this,
only 33% of respondents indicated they always ask patients if they are content with the quality of
their life during treatment (Table 3). Additionally, none of the respondents indicated they
consistently ask patients about key quality of life indicators such as acceptance of their illness
(Table 4) or how they are coping with their illness (Table 5).
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Table 1
RN Comfort with Asking Cancer Patients About Health-Related Quality of Life Measures.

Table 2
RN Knowledge About Health-Related Quality of Life Measures for Cancer Patients.

19

HRQOL ASSESSMENT
Table 3
Frequency of Assessing Cancer Patients Contentment with Their Quality of Life During
Treatment.

Table 4
Frequency of Assessing if Cancer Patients Have Accepted Their Illness.
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Table 5
Frequency of Asking Cancer Patients if They Are Satisfied with How They Are Coping with Their
Illness.

Following the survey, a training was held for the RN staff of the outpatient
hematology/oncology infusion suite (n = 3). The training defined HRQOL, outlined the
importance of gathering HRQOL data for patients undergoing cancer treatment, described the
FACT-G assessment, explained why it was chosen, and instructed the providers on how to
administer the assessment and calculate the subscale and overall assessment scores.
Use of the FACT-G launched on January 24, 2022. A total of seven patients (n = 7) met
the eligibility criteria during the 6-week pilot period and completed the assessment. The
assessment was administered by the RN staff of the outpatient hematology/oncology infusion
suite. There was no missing data. All patients completed the assessment in full, without skipping
any items. Two patients (n = 2) received the assessment twice during the pilot period. Both
patients showed improvement in their subscale scores and overall FACT-G assessment score
over baseline. Table 6 shows the comparison between both patient’s overall FACT-G score on
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the first assessment versus the second assessment. Table 7 shows the FACT-G assessment scores
for all seven patients.
Table 6
FACT-G Score 1 vs. FACT-G Score 2

FACT-G SCORE 1 VS. FACT-G SCORE 2
Overall FACT-G Score 2

40

46.5

82

91

Overall FACT-G Score 1

PATIE NT 1

PATIE NT 2

Table 7
FACT-G Assessment Scores

FACT-G ASSESSMENT SCORES
SWB Subscore (0-28)

EWB Subscore (0-24)

FWB Subscore (0-28)

Overall FACT-G Score (0-108)

90

20
17
19
13

21
23
23
20

25
28
18
26

20
25
19
18

26
26
19
19

PATIE NT 1

24
24.5
21
14

10
10
11
9

40

69

82

87

83.5

97

PWB Subscore (0-28)

PATIE NT 2

PATIE NT 3

PATIE NT 4

PATIE NT 5

PATIE NT 6

PATIE NT 7

Patient 1 scored very low on each subscale as well as the overall assessment. The
patient’s low score prompted the project team to develop a set of benchmarks around each
subscale score and identify nursing interventions (Appendix B) so patients who score below a
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specific threshold can receive appropriate follow-up care. These nursing interventions also
prompted the establishment of a referral pathway to connect outpatient hematology/oncology
patients to care management services, which was an organizational priority at the beginning of
the project.
Phase III – Sustaining the Project
Following the 6-week pilot period, the RN staff of the outpatient hematology/oncology
infusion suite (n = 3) completed the same 15-question HRQOL survey to determine if their
knowledge and consistent assessment of HRQOL measures in cancer patients had changed.
Interestingly, the responses on the post-test showed no difference from the pre-test baseline,
which was unexpected.
A focus group was conducted to determine what went well with the implementation and
identify barriers to continued use of the FACT-G assessment. The focus group consisted of the
RN staff of the outpatient hematology/oncology infusion suite (n = 2) and a patient (n = 1) who
had completed the FACT-G assessment. Themes from the focus group included (1)
implementation of the FACT-G went smoothly, (2) the FACT-G assessment is easy to use and
understand, and (3) the FACT-G helps patients identify their symptoms and communicate their
needs to providers. Remembering to administer the assessment was identified as the only barrier
to its continued use.
The final phase of the project also involved creating a FACT-G Assessment Policy
(Appendix C), a FACT-G Assessment Procedure (Appendix D), and a FACT-G Assessment Job
Aid (Appendix E) to standardize the use and administration of the assessment tool and ensure its
sustainability within the organization.
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Summary

The primary aim of the project was to implement a valid, reliable HRQOL assessment
tool in an outpatient hematology/oncology infusion suite at a small critical access hospital in
rural New Hampshire. Following a search of existing nursing and allied health care literature, the
FACT-G assessment tool was identified and implemented into daily clinical practice at the
project site. Seven patients met the inclusion criteria and completed the assessment during the
pilot period. The project team also created benchmarks around patient scores and identified
specific nursing interventions to ensure patients who score low on the assessment receive
appropriate follow-up care. Finally, the team developed a policy, procedure, and job aid to
establish a standardized approach to HRQOL assessments at the project site. These tools will
help replicate the project's success at other similarly sized hospitals with outpatient
hematology/oncology infusion suites within the D-H network.
A secondary aim was to educate the RN staff of the outpatient hematology/oncology
infusion suite on the importance of gathering HRQOL assessment data on cancer patients
undergoing treatment to facilitate patient-provider communication and better identify the
patient’s difficulties and needs. Interestingly, the pre-test and post-test HRQOL survey data did
not show a change in RN knowledge or assessment of HRQOL measures. However, the focus
group results revealed the FACT-G assessment tool has helped patients identify their symptoms
and communicate their needs to providers. Additionally, the collection of HRQOL data has
prompted the development of a referral pathway to connect outpatient hematology/oncology
patients to care management services, which was an organizational priority at the beginning of
the project.

HRQOL ASSESSMENT

25

The final aim of the project was to incorporate the FACT-G assessment tool into the
hospital’s EMR. Unfortunately, the licensing agreement with the organization that created the
FACT-G assessment tool, the FACIT Group, prevented the project team from incorporating the
FACT-G assessment into the EMR. Instead, the project team pivoted to administering the
assessment on paper, scanning completed assessments into the medical record and documenting
the patient’s assessment scores in the narrative note for each encounter.
Overall, the project's strengths included a project team that was committed to adopting an
HRQOL assessment tool into daily clinical practice and developing structures to support its
continued use. Another critical strength was using a small-scale iterative approach to test
interventions, which enabled rapid assessment of solutions and provided flexibility to make
changes as needed.
Interpretation
The direct involvement of the hematology/oncology infusion suite staff was instrumental
in achieving the project's primary outcome. As care providers to the population of interest, their
input was critical in helping the project team identify potential barriers to successfully
implementing an HRQOL assessment tool and developing solutions to address these challenges.
Specifically, they assisted the project team in developing a work-around to the unexpected issue
of being unable to incorporate the FACT-G assessment and score sheet into the hospital's EMR.
They were also instrumental in helping the project team develop nursing interventions to
accompany each subscale score on the FACT-G Benchmarks and Interventions Job Aid
(Appendix B). Moreover, they played a crucial role in establishing the referral process with care
management to ensure appropriate follow-up for patients who score low on the social/family
well-being and emotional well-being subscales.
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Selecting a valid, reliable HRQOL assessment tool that is easy to understand, takes less
than 10 minutes to complete, and produces a quantitative score was also a significant factor in
achieving the project's primary outcome. This intervention is supported by Atallah et al. (2020)
and Fragola (2020). They report that implementing an HRQOL assessment in an ambulatory
oncology clinic is feasible if the questionnaire is easy for patients to understand and complete.
Establishing a policy, procedure, and job aids to support using the HRQOL assessment
tool was also important. Specifically, the development of nursing interventions for each subscale
score to ensure patients who score low on the assessment receive appropriate follow-up care.
Atallah et al. (2020) support this intervention. They indicate it is paramount for providers to
develop actionable policies and interventions that correspond to symptom burden to improve
clinical care and the patients' quality of life.
Adopting an HRQOL assessment tool in the public domain was another critical factor in
achieving the primary outcome of the project. Since the HRQOL assessment tool was public,
there was no cost associated with adopting the measure. This cost-effective strategy ensures that
other small, rural hospitals within the D-H system with outpatient hematology/oncology infusion
suites can implement this project.
Finally, after implementing the HRQOL assessment tool at the project site, both patients
and providers reported increased patient-provider communication regarding HRQOL issues and
improved provider awareness of patients’ problems. These findings are consistent with studies
published by Hilarius et al. (2008) and Atallah et al. (2020). They also note that the use of an
HRQOL assessment in daily clinical oncology nursing practice resulted in improved
communication between patients and providers and increased nursing awareness of patients’
levels of daily activity, pain, and overall quality of life.
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Limitations

There are several limitations of this project which must be acknowledged. First, the
project site serves a small number of patients with a wide variety of hematologic and oncologic
malignancies. The objective of this project was to implement a generic HRQOL assessment tool
into daily clinical practice. Therefore, the evaluation of disease-specific HRQOL assessment
tools for each malignancy treated in the outpatient hematology/oncology infusion suite was not
part of the project. Second, the number of RN staff employed in the outpatient
hematology/oncology infusion suite is small, which impacted the ability to determine if a
statistically significant difference existed in the pre-test and post-test scores on the HRQOL
survey. Third, this was a pilot project. Therefore, the project team was unable to assess the
longitudinal impact of the HRQOL assessment tool on clinical encounters and symptom
management.
Conclusions
In conclusion, implementing a valid, reliable HRQOL assessment tool into daily clinical
practice at an outpatient hematology/oncology infusion suite at a critical access hospital in rural
New Hampshire was feasible and endorsed by both patients and providers. The FACT-G was
found to be clinically relevant, identify areas of need, and facilitate patient-provider
communication. Other outpatient hematology/oncology clinics within the D-H system should
consider implementing the FACT-G to improve patient-centered care. More data is needed to
determine if this strategy will improve outcomes for hematology/oncology patients receiving
treatment in the outpatient setting.
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Appendix A: FACT-G Assessment Tool
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Appendix B: FACT-G Assessment Benchmarks and Interventions

Job Aid
Title:

Keywords

FACT-G Assessment Benchmarks
and Interventions – Job Aid

Job Aid
ID:

FACT-G, hematology/oncology, assessment, outpatient, health-related quality of
life, HRQOL

Physical Well-Being

Physical Well-Being

Benchmark: Score of 0-10

Benchmark: Score of 11-19

Benchmark: Score of 0-10

Benchmark: Score of 11-19

Interventions:
• Referral to PCP and
Palliative Care for
symptom management
• Follow-up by Oncology
Provider and Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of physical well-being
using FACT-G
• Documentation of score
and interventions in
patient’s medical
record
Social Well-Being
Interventions:
• Referral to Community
Health Worker (Office
of Care Management)
for coordination of
counseling and
emotional support
services
• Follow-up by Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of social well-being
using FACT-G
• Documentation of score
and interventions in
patient’s medical
record

Interventions:
• Follow-up by Oncology
Provider and Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of physical well-being
using FACT-G
• Documentation of
score and interventions
in patient’s medical
record

Social Well-Being

Interventions:
• Follow-up by Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of social well-being
using FACT-G
• Documentation of
score and interventions
in patient’s medical
record

Physical Well-Being

Benchmark: Score of 20-28

Interventions:
• Continued assessment
of physical well-being
using FACT-G
• Documentation of
score and
interventions in
patient’s medical
record

Social Well-Being

Benchmark: Score of 20-28

Interventions:
• Continued assessment
of social well-being
using FACT-G
• Documentation of
score and
interventions in
patient’s medical
record

HRQOL ASSESSMENT
Emotional Well-Being

33
Emotional Well-Being

Benchmark: Score of 0-8

Benchmark: Score of 9-16

Benchmark: Score of 0-10

Benchmark: Score of 11-19

Interventions:
• Referral to Community
Health Worker (Office
of Care Management)
for coordination of
counseling and
emotional support
services
• Follow-up by Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of emotional well-being
using FACT-G
• Documentation of score
and interventions in
patient’s medical
record
Functional Well-Being
Interventions:
• Referral to Physical
Therapy and
Occupational Therapy
for assistance with
activities of daily living
and working
• Follow-up by Oncology
Provider and Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of functional well-being
using FACT-G
• Documentation of score
and interventions in
patient’s medical
record

Interventions:
• Follow-up by Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of emotional well-being
using FACT-G
• Documentation of
score and interventions
in patient’s medical
record

Functional Well-Being

Interventions:
• Follow-up by Oncology
Provider and Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of functional wellbeing using FACT-G
• Documentation of
score and interventions
in patient’s medical
record

Emotional Well-Being

Benchmark: Score of 17-24

Interventions:
• Continued assessment
of emotional wellbeing using FACT-G
• Documentation of
score and
interventions in
patient’s medical
record

Functional Well-Being

Benchmark: Score of 20-28

Interventions:
• Continued assessment
of functional wellbeing using FACT-G
• Documentation of
score and
interventions in
patient’s medical
record
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Benchmark: Score of 0-36

Interventions:
• Referral to services
identified above as
needed
• Follow-up by Oncology
Provider and Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of health-related
quality of life using
FACT-G
• Documentation of score
and interventions in
patient’s medical
record
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Total FACT-G Score

Benchmark: Score of 37-72

Interventions:
• Follow-up by Oncology
Provider and Infusion
Suite RN for ongoing
assessment of
symptoms
• Continued assessment
of health-related
quality of life using
FACT-G
• Documentation of
score and interventions
in patient’s medical
record

Total FACT-G Score

Benchmark: Score of 73108

Interventions:
• Continued assessment
of health-related
quality of life using
FACT-G
• Documentation of
score and
interventions in
patient’s medical
record
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Appendix C: FACT-G Assessment Policy

Policy
Title:

Keywords

FACT-G Assessment Policy

Policy ID:

FACT-G, hematology/oncology, assessment, outpatient, health-related quality of
life, HRQOL

Purpose:

To establish a standardized, centralized approach to the assessment of health-related
quality of life (HRQOL) measures in hematology/oncology patients receiving treatment
at New London Hospital’s outpatient hematology/oncology infusion suite.

Policy Scope:

Adult cancer patients, age 18 and older, receiving care at New London Hospital’s
outpatient hematology/oncology infusion suite are eligible for assessment using the
Functional Assessment of Cancer Therapy – General (FACT-G).
Patients will be excluded if they:
• Do not have a hematology/oncology diagnosis.
• Are under the age of 18.
• Are unable to complete the assessment due to mental status that could invalidate
the results.
• Are non-English speaking/reading and no native language translation or
interpreter is available.
• Decline to complete the assessment.

Definitions:
•

Health-Related Quality of Life (HRQOL): Health-related quality of life is a
multidimensional concept that includes physical, psychological, and social functioning. It
is defined as an individual’s perceived physical and mental health over time (Centers for
Disease Control and Prevention [CDC], 2021).

•

HRQOL Assessments: HRQOL assessments capture the patient’s perception of how
disease and treatment affect their sense of overall function and well-being (Office of
Disease Prevention and Health Promotion [ODPHP], 2021). HRQOL assessments are an
essential component of providing comprehensive cancer care and establishing goals of
treatment (Fragola, 2020).

•

Functional Assessment of Cancer Therapy – General (FACT-G): The FACT-G is one
of the most widely used patient-reported HRQOL outcomes measures in cancer research.
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It is self-administered by the patient and takes 5 minutes to complete. The FACT-G
produces a quantitative score that can be tracked over time using a 5-point Likert-type
numeric ranking system and assess four (4) key domains – physical well-being, social
well-being, emotional well-being, and functional well-being (FACIT Group, 2021).

Policy Statements:
•

Patient’s make treatment decisions based on their perceived HRQOL. Therefore, HRQOL
assessments are critical to the patient’s overall outcomes (Fragola, 2020).

•

HRQOL assessments are essential for prioritizing problems, understanding what matters
to the patient, and assessing treatment-related changes the patient is experiencing
(Fragola, 2020).

•

Research shows HRQOL assessments positively impact the patient’s overall sense of
well-being, improve patient-provider communication and the patient-provider
relationship, adherence to treatment regimens, and decrease unnecessary health-care
utilization via preventative care (Bridge et al., 2019).

References:
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Bridge, E., Conn, L. G., Dhanju, S., Singh, S. & Moody, L. (2019). The patient
experience of ambulatory cancer treatment: A descriptive study. Current Oncology,
26(4), e482-493.
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Retrieved from https://www.cdc.gov/hrqol/index.htm
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FACIT Group. (2021). FACT-G: Functional assessment of cancer therapy-general.
Retrieved from https://www.facit.org/measures/FACT-G
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Fragola, M. (2020). Patient-reported outcomes and assessment of quality of life: A focus
on multiple myeloma. Journal of the Advanced Practitioner in Oncology, 11(5), 513-520.
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Appendix D: FACT-G Assessment Procedure

Procedure
Title:
Keywords

FACT-G Assessment Procedure

Procedure
ID:

FACT-G, hematology/oncology, assessment, outpatient, health-related quality
of life, HRQOL

Purpose:

To standardize the administration of the Functional Assessment of Cancer Therapy –
General (FACT-G) health-related quality of life (HRQOL) assessment measure in
hematology/oncology patients receiving treatment at New London Hospital’s outpatient
hematology/oncology infusion suite.

Procedure Scope:

Adult cancer patients, age 18 and older, receiving care at New London Hospital’s
outpatient hematology/oncology infusion suite are eligible for assessment using the
Functional Assessment of Cancer Therapy – General (FACT-G).
Patients will be excluded if they:
• Do not have a hematology/oncology diagnosis.
• Are under the age of 18.
• Are unable to complete the assessment due to mental status that could invalidate
the results.
• Are non-English speaking/reading and no native language translation or
interpreter is available.
• Decline to complete the assessment.

Definitions:
•

Health-Related Quality of Life (HRQOL): Health-related quality of life is a
multidimensional concept that includes physical, psychological, and social functioning. It
is defined as an individual’s perceived physical and mental health over time (Centers for
Disease Control and Prevention [CDC], 2021).

•

HRQOL Assessments: HRQOL assessments capture the patient’s perception of how
disease and treatment affect their sense of overall function and well-being (Office of
Disease Prevention and Health Promotion [ODPHP], 2021). HRQOL assessments are an
essential component of providing comprehensive cancer care and establishing goals of
treatment (Fragola, 2020).
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Functional Assessment of Cancer Therapy – General (FACT-G): The FACT-G is one
of the most widely used patient-reported HRQOL outcomes measures in cancer research.
It is self-administered by the patient and takes 5 minutes to complete. The FACT-G
produces a quantitative score that can be tracked over time using a 5-point Likert-type
numeric ranking system and assess four (4) key domains – physical well-being, social
well-being, emotional well-being, and functional well-being (FACIT Group, 2021).

Equipment:
•
•
•

FACT-G Assessment
FACT-G Scoring Sheet
FACT-G Data Sheet

Procedure:

1. Determine if the patient meets inclusion criteria when they arrive for their scheduled
appointment at the New London Hospital outpatient hematology/oncology infusion suite.
2. If the patient meets criteria, locate the FACT-G Assessment.
a. Ideally, the FACT-G Assessment will be administered three (3) times:
i. Once at the beginning of an eligible patient’s treatment cycle.
ii. Once at the midpoint of an eligible patient’s treatment cycle.
iii. Once at the end of an eligible patient’s treatment cycle.
b. At a minimum, the FACT-G Assessment should be administered once per
calendar year.
3. If the patient meets criteria, obtain the patient’s verbal consent to administer the FACT-G
Assessment.
4. Apply the patient’s ID label to the FACT-G Assessment.
5. Ask the patient to read the brief directions at the top of each page of the FACT-G
Assessment.
6. After the patient’s understanding has been confirmed, encourage the patient to complete
every item in order without skipping any items.
7. Ask the patient to circle the response that is most applicable to their symptoms for the
past seven (7) days. For example, if a patient is not currently receiving treatment, they
should circle “not at all” to the question “I am bothered by the side effects of treatment.”
8. Once the patient has completed the FACT-G Assessment, calculate the score using the
FACT-G Scoring Sheet, which is an Excel spreadsheet available on a shared drive.
a. Record answers in the “item response” column on the FACT-G Scoring Sheet in
Excel.
i. If the patient did not answer a specific item, do not include a value for that
item.
ii. Perform reversals as indicated and sum individual items to obtain a score.
1. For example, if a patient circles “very much” (which produces a
score of 4) to the question “I have a lack of energy” then the
provider would subtract this value from 4 to give an overall score
of 0 for this question.
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a. All the questions in the subscale Physical Well-Being
(PWB) are negatively stated as are most of the items in
subscale Emotional Well-Being (EWB).
i. The formulas for these calculations are already built
into the FACT-G Scoring Sheet in Excel.
b. Multiply the sum of the item scores by the number of items in the subscale, then
divide by the number of items answered to produce the subscale score.
i. The formulas for these calculations are already built into the FACT-G
Scoring Sheet in Excel.
c. Add the subscale scores to derive the total FACT-G score.
i. The formulas for these calculations are already built into the FACT-G
Scoring Sheet in Excel.
d. The higher the score, the better the patient’s quality of life.
9. Document on the FACT-G Data Sheet, which is an Excel spreadsheet available on a
shared drive.
a. Patient last name
b. Patient first name
c. Patient medical record number
d. Patient date of birth
e. Date the FACT-G Assessment was administered
f. Score for each subscale
g. Overall FACT-G Assessment score
10. Initiate referrals and additional interventions as indicated based on the patient’s score for
each subscale and the patient’s overall FACT-G Assessment score (see FACT-G
Benchmarks and Interventions – Job Aid).
11. Document that the FACT-G Assessment was administered, and any referrals or other
actions taken in the patient’s encounter note.
12. Send the completed FACT-G Assessment to medical records so it can be scanned into the
patient’s chart under the Media tab.
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Appendix E: FACT-G Assessment Job Aid

Job Aid
Title:

Keywords

FACT-G Assessment – Job Aid

Job Aid
ID:

FACT-G, hematology/oncology, assessment, outpatient, health-related quality of
life, HRQOL

